Drug
Prasugrel
Prasugrel: highest development phase Phase 3, developed by Eli Lilly. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Prasugrel NCT01794000 | Phase 3 | Sickle Cell Disease |
| Prasugrel NCT01167023 | Phase 2 | Sickle Cell Anemia |
| prasugrel NCT00642174 | Phase 2 | Diabetes Mellitus |
Latest
No recent events.
Follow Prasugrel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.